Lipoprotein Lipase (LPL) Peptide
LPL
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940389
Quick Overview for Lipoprotein Lipase (LPL) Peptide (ABIN940389)
Target
Lipoprotein Lipase (LPL)
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- LGYEINKVRA KRSSKMYLKT RSQMPYKVFH YQVKIHFSGT ESETHTNQAF
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LPL antibody,
Alternative Names: LPL control peptide, LPL antibody Blocking Peptide, Anti-LPL Blocking Peptide, lipoprotein lipase Blocking Peptide, HDLCQ11 Blocking Peptide, LIPD Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Lipoprotein Lipase (LPL)
-
Background
- LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
-
Molecular Weight
- 50 kDa
Target
-
You are here:
